Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Investigational New Drugs|October 21, 2010
Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumorsIsamu Okamoto, Toshio Shimizu, Masaki Miyazaki, et al.
Cancer Science|March 9, 2021
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I studyShunji Takahashi, Yutaka Fujiwara, Kenji Nakano, et al.
Investigational New Drugs|March 23, 2016
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumorsToshio Shimizu, Takashi Seto, Fumihiko Hirai, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2010
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumorsYasuhito Fujisaka, Yasuhide Yamada, Noboru Yamamoto, et al.
BMC Neurology|May 1, 2026
Cluster analysis of heart rate variability reveals subgroups with preserved and early-impaired autonomic regulation in amyotrophic lateral sclerosisJuri Sawada, Yuki Nakayama, Keiichi Shimatani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2026
Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M)Hiroaki Kanemura, Junko Tanizaki, Koji Matsumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid TumorsToshio Shimizu, Yutaka Fujiwara, Kan Yonemori, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 21, 2026
Addendum to the 2023 clinical practice guidelines for amyotrophic lateral sclerosis in Japan: approval and integration of novel disease-modifying therapiesHitoshi Warita, Makoto Urushitani, Naoki Atsuta, et al.
Acta Neuropathologica Communications|October 8, 2016
Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V)Kentaro Hayashi, Yoko Mochizuki, Ryoko Takeuchi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 5, 2015
Caregiver treatment satisfaction is improved together with children's asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptomsShigemi Yoshihara, Noriko Kanno, Hironobu Fukuda, et al.
Pageof 22